author-photo

David M. Thomas

43

Papers

232

Citations

Citation Trend

Filter By

Papers (30) Sort By

Journal Conference Others

Attack Vectors and Susceptibilities of the Modbus in TCP/IP Model

2021 INFOCOM | International Conference on Computer Communications
Show All
- Source
- Cite
- Save
Citations (0)
PD ‐1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma

2020
Show All
- Source
- Cite
- Save
Citations (1)
A signal-seeking trial of olaparib and durvalumab in homologous repair-deficient tumors: A sub-study of the cancer molecular screening and therapeutics (MoST) program.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Return of results after somatic tumor mutation profiling in advanced cancer: Psychological impacts.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Heritable cancer risk in the genomic era

2020 Pathology
- Mandy L. Ballinger
- David M. Thomas
Show All
- Source
- Cite
- Save
Citations (0)
Oakland University William Beaumont School of Medicine

2020 Academic Medicine
Show All
- Source
- Cite
- Save
Citations (0)
NOMINATOR: Feasibility of genomic testing of rare cancers to match cancer to treatment.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Medical oncologists’ experience with returning molecular tumor profiling to patients.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The Cancer Molecular Screening and Therapeutics Program (MoST): Actionable mutation frequencies in a population with rare and less common cancers.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

2019 The Lancet
Show All
- Source
- Cite
- Save
Citations (122)